Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction

Objective: Characteristic parkinsonism is the major comorbidity of dementia with Lewy bodies (DLB). We aimed to differentiate DLB from Alzheimer's disease (AD) with motor dysfunction using a composite scale with a characteristic motor dysfunction questionnaire (MDQ) and dopamine transporter (DA...

Full description

Bibliographic Details
Main Authors: Pai-Yi Chiu, Cheng-Yu Wei, Guang-Uei Hung, Shey-Lin Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.709215/full
id doaj-8932fcbf7f484ba598a0f01f1506867d
record_format Article
spelling doaj-8932fcbf7f484ba598a0f01f1506867d2021-08-11T07:34:04ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-08-011310.3389/fnagi.2021.709215709215Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor DysfunctionPai-Yi Chiu0Pai-Yi Chiu1Cheng-Yu Wei2Guang-Uei Hung3Shey-Lin Wu4Shey-Lin Wu5Department of Neurology, Show Chwan Memorial Hospital, Changhua, TaiwanDepartment of Nursing, College of Nursing and Health Sciences, Da-Yeh University, Changhua, TaiwanDepartment of Neurology, Chang Bing Show Chwan Memorial Hospital, Changhua, TaiwanDepartment of Nuclear Medicine, Chang Bing Show Chwan Memorial Hospital, Changhua, TaiwanDepartment of Neurology, Changhua Christian Hospital, Changhua, TaiwanDepartment of Biomedical Sciences, Da-Yeh University,Changhua, TaiwanObjective: Characteristic parkinsonism is the major comorbidity of dementia with Lewy bodies (DLB). We aimed to differentiate DLB from Alzheimer's disease (AD) with motor dysfunction using a composite scale with a characteristic motor dysfunction questionnaire (MDQ) and dopamine transporter (DAT) imaging. It could help detect DLB easily in healthcare settings without movement disorder specialists.Methods: This is a two-phase study. In the design phase, seven questions were selected and composed of a novel MDQ. In the test phase, all participants with DLB, AD, or non-dementia (ND) control completed dementia and parkinsonism survey, the novel designed questionnaire, DAT imaging, and composite scales of MDQ and DAT. The cutoff scores of the MDQ, semiquantitative analysis of the striatal–background ratio (SBR) and visual rating of DAT, and the composite scale of MDQ and DAT for discriminating DLB from AD or ND were derived and compared.Results: A total of 277 participants were included in this study (126 with DLB, 86 with AD, and 65 with ND). Compared with the AD or ND groups, the DLB group showed a significantly higher frequency in all seven items in the MDQ and a significantly lower SBR. For discrimination of DLB from non-DLB with MDQ, SBR, and composite scale, the cutoff scores of 3/2, 1.37/1.38, and 6/5 were suggested for the diagnosis of DLB with the sensitivities/specificities of 0.91/0.72, 0.91/0.80, and 0.87/0.93, respectively. The composite scale significantly improved the accuracy of discrimination compared with either the MDQ or SBR.Conclusion: This study showed that the novel designed simple questionnaire was a practical screening tool and had similar power to DAT scanning to detect DLB. The questionnaire can be applied in clinical practice and population studies for screening DLB. In addition, the composite scale of MDQ and DAT imaging further improved the diagnostic accuracy, indicating the superiority of the dual-model diagnostic tool.https://www.frontiersin.org/articles/10.3389/fnagi.2021.709215/fullAlzheimer's diseasedementia with Lewy bodiesnon-dementiamotor dysfunctionstriatal–background ratio
collection DOAJ
language English
format Article
sources DOAJ
author Pai-Yi Chiu
Pai-Yi Chiu
Cheng-Yu Wei
Guang-Uei Hung
Shey-Lin Wu
Shey-Lin Wu
spellingShingle Pai-Yi Chiu
Pai-Yi Chiu
Cheng-Yu Wei
Guang-Uei Hung
Shey-Lin Wu
Shey-Lin Wu
Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction
Frontiers in Aging Neuroscience
Alzheimer's disease
dementia with Lewy bodies
non-dementia
motor dysfunction
striatal–background ratio
author_facet Pai-Yi Chiu
Pai-Yi Chiu
Cheng-Yu Wei
Guang-Uei Hung
Shey-Lin Wu
Shey-Lin Wu
author_sort Pai-Yi Chiu
title Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction
title_short Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction
title_full Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction
title_fullStr Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction
title_full_unstemmed Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction
title_sort motor dysfunction questionnaire and dopamine transporter imaging composite scale improve differentiating dementia with lewy bodies from alzheimer's disease with motor dysfunction
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2021-08-01
description Objective: Characteristic parkinsonism is the major comorbidity of dementia with Lewy bodies (DLB). We aimed to differentiate DLB from Alzheimer's disease (AD) with motor dysfunction using a composite scale with a characteristic motor dysfunction questionnaire (MDQ) and dopamine transporter (DAT) imaging. It could help detect DLB easily in healthcare settings without movement disorder specialists.Methods: This is a two-phase study. In the design phase, seven questions were selected and composed of a novel MDQ. In the test phase, all participants with DLB, AD, or non-dementia (ND) control completed dementia and parkinsonism survey, the novel designed questionnaire, DAT imaging, and composite scales of MDQ and DAT. The cutoff scores of the MDQ, semiquantitative analysis of the striatal–background ratio (SBR) and visual rating of DAT, and the composite scale of MDQ and DAT for discriminating DLB from AD or ND were derived and compared.Results: A total of 277 participants were included in this study (126 with DLB, 86 with AD, and 65 with ND). Compared with the AD or ND groups, the DLB group showed a significantly higher frequency in all seven items in the MDQ and a significantly lower SBR. For discrimination of DLB from non-DLB with MDQ, SBR, and composite scale, the cutoff scores of 3/2, 1.37/1.38, and 6/5 were suggested for the diagnosis of DLB with the sensitivities/specificities of 0.91/0.72, 0.91/0.80, and 0.87/0.93, respectively. The composite scale significantly improved the accuracy of discrimination compared with either the MDQ or SBR.Conclusion: This study showed that the novel designed simple questionnaire was a practical screening tool and had similar power to DAT scanning to detect DLB. The questionnaire can be applied in clinical practice and population studies for screening DLB. In addition, the composite scale of MDQ and DAT imaging further improved the diagnostic accuracy, indicating the superiority of the dual-model diagnostic tool.
topic Alzheimer's disease
dementia with Lewy bodies
non-dementia
motor dysfunction
striatal–background ratio
url https://www.frontiersin.org/articles/10.3389/fnagi.2021.709215/full
work_keys_str_mv AT paiyichiu motordysfunctionquestionnaireanddopaminetransporterimagingcompositescaleimprovedifferentiatingdementiawithlewybodiesfromalzheimersdiseasewithmotordysfunction
AT paiyichiu motordysfunctionquestionnaireanddopaminetransporterimagingcompositescaleimprovedifferentiatingdementiawithlewybodiesfromalzheimersdiseasewithmotordysfunction
AT chengyuwei motordysfunctionquestionnaireanddopaminetransporterimagingcompositescaleimprovedifferentiatingdementiawithlewybodiesfromalzheimersdiseasewithmotordysfunction
AT guangueihung motordysfunctionquestionnaireanddopaminetransporterimagingcompositescaleimprovedifferentiatingdementiawithlewybodiesfromalzheimersdiseasewithmotordysfunction
AT sheylinwu motordysfunctionquestionnaireanddopaminetransporterimagingcompositescaleimprovedifferentiatingdementiawithlewybodiesfromalzheimersdiseasewithmotordysfunction
AT sheylinwu motordysfunctionquestionnaireanddopaminetransporterimagingcompositescaleimprovedifferentiatingdementiawithlewybodiesfromalzheimersdiseasewithmotordysfunction
_version_ 1721211570218860544